Therefore, drugs that improve insulin resistance or activate PPARγ in the brain can theoretically be beneficial in preventing Alzheimer’s disease or dementia [2,9]. The gene discussed is PPARG; the disease is early-onset autosomal dominant Alzheimer disease.